- Download 105
- File Size 0.00 KB
- File Count 1
- Create Date January 27, 2021
- Last Updated January 6, 2022
2021 New Updates: China NMPA Medical Device Clinical Pathways
Want to reduce your device’s clinical trial costs and accelerate its time to market in China? It’s possible when you use the latest China National Medical Products Administration (NMPA) regulatory developments to your advantage.
Now more than ever, NMPA’s regulatory approval process is going through transformational reform. Device makers — especially non-China manufacturers — have more options to supplement the traditional comprehensive clinical trial.